| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Precision Medicine Scotland Innovation Centre We bring together innovators, clinicians and researchers to facilitate the adoption of Precision Medicine in Scotland. Welcome to Precision Medicine Scotland’s home on LinkedIn. Follow us for updates on collaboration opportunities, funding news and the latest updates on Scotland’s advances in Precision Medicine. Precision Medicine Scotland Innovation Centre (PMS-IC) enables the development of new products and services for a global market. PMS-IC is an Innovation Centre that brings together industry innovators, clinicians and world-class researchers to collaborate on precision medicine opportunities. Our focus is on linking Scotland’s domain expertise, data assets and world-class delivery infrastructure to accelerate the adoption of … Type: | 3 | 0 | 3 | 7 |
 | iOnctura Developing selective cancer therapies against targets that play critical roles in multiple tumor survival pathways iOnctura is a clinical-stage biotech developing selective cancer therapies against targets that play critical roles in multiple tumor survival pathways such as cellular proliferation; escape from immune detection; and drug resistance. iOnctura’s pioneering approach to drug development is expected to offer significant clinical benefits over the traditional approach of targeting a single pathway alone. iOnctura has progressed two therapeutic candidates into mid-stage clinical development: IOA-244, a highly selective allosteric inhibitor of PI3Kδ to treat Treg-driven tumors; and IOA-289, a highly selective, non-competitive autotaxin (ATX) inhibitor … Type: | 3 | 1 | 2 | 22 |
 | SynaptixBio Ltd. Developing therapies for severe leukodystrophies Overview SynaptixBio is a rare disease biotech company that is pioneering ground-breaking treatments for severe leukodystrophies and other childhood neurodegenerative diseases. SynaptixBio’s mission is to deliver gene therapies for fatal leukodystrophies in children caused by loss of function or mutation in a single gene. Using a breadth of platforms including antisense oligonucleotide (ASO)-based technology, we can silence the expression of the toxic gene to reverse disease progression. This approach will create life saving treatments for severe genetic diseases that affect the central nervous system. Pharmaceutical, Biotech, Leukodystrophy, Rare Disease, H-ABC, Hypomyelination, Basal Ganglia, Cerebrllum, Neurology, … Type: | 2 | 0 | 2 | 3 |
 | Clinithink AI in healthcare - Harness the power of unstructured data Nowhere is it more critical to have the ability to use ALL available data than within healthcare. Clinithink's solutions transform unstructured clinical narrative into structured patient information. Whether it’s to better understand a vulnerable population, highlight important phenotypes or to reduce the risk of denied claims for providers, Clinithink’s solutions provide healthcare decision-makers with better information and insight. Founded in 2009 on the premise that unlocking unstructured clinical data within patient records and returning it as structured, usable clinical information cracks wide open the realm of possibilities to solve the … Type: | 3 | 1 | 3 | 57 |
 | Brainomix AI Enabled Precision Medicine We specialize in the creation of AI-powered imaging biomarkers to enable precision medicine for better treatment decisions. Since launching as a spin-out from the University of Oxford in 2010, we have developed award-winning, AI-powered imaging biomarkers and software solutions, assisting physicians across the world to make better life-saving decisions. Type: | 8 | 2 | 7 | 73 |
 | Havas Lynx Creating an impact that matters for our brands, our people, and our world. We are a leading healthcare communications agency with a full-service global offering and over 500 multi-disciplinary specialists in Manchester, London, and New York. For 36 years, we’ve brought together fresh perspectives, creative thinking, and a progressive approach to partner with our clients, healthcare professionals and patients in finding solutions for the modern-day healthcare landscape. Ultimately, everything we do is about making a genuine and lasting impact. Brand strategy and positioning and Fully integrated multi-channel campaign development Type: | 2 | 0 | 1 | 484 |
 | Ochre Bio Ochre Bio is a biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for important liver health challenges, from increasing donor liver supply to reducing cirrhosis complications. To learn more, please visit www.ochre-bio.com. | 13 | 0 | 12 | 53 |
 | BenevolentAI Uniting human and machine intelligence to discover new ways to treat disease. BenevevolentAI is a global pioneer and leader in AI-augmented drug discovery. We serve patients by leveraging our proprietary and validated Benevolent Platform that integrates AI and science to uncover new biology, predict novel targets and develop first-in-class or best-in-class drugs for complex diseases. By applying proprietary advanced AI tools, in combination with in-house scientific expertise and wet-lab facilities, Benevolent is well-positioned to identify and accelerate novel drug discoveries. Artificial Intelligence, Drug Development, Scientific Innovation, Machine Learning, Deep Learning, Big Data, Pharmaceutical, BioPharma, and Drug Discovery Type: | 3 | 0 | 3 | 275 |
 | Rubica Change & Analytics for Life Sciences Organisational change consultancy specialising in culture and capability transformation within Life Sciences. We are an organisational change consultancy. We partner with Life Science organisations to help them navigate complex and ambiguous change - translating what can often feel woolly and opaque into a clear direction of travel. Our work focuses on creating the mindsets, skills and sustained behaviour change needed to deliver the cultural, strategic and performance goals being sought. Commercially Focused Change, Performance Measurement, Performance Dashboards, Performance Analytics, Organisational Change, Change Management, customer centricity, culture change, and culture & engagement Type: | 4 | 0 | 4 | 15 |
 | Oxford PharmaGenesis Providing innovative services to the healthcare industry, professional societies and patient groups. Oxford PharmaGenesis is a HealthScience communications consultancy. We are the largest independently owned and financed company in the medical communications sector. Founded in 1998, our award-winning organization now comprises more than 500 talented people working from offices and homes worldwide. We are connected by a strong company culture and a clear mission: to accelerate adoption of evidence-based innovations for patients in areas of unmet medical need. Contact us to find out how we apply powerful thinking, dedicated to your success. Medical affairs, Commercial and Marketing, Value demonstration, Real-world … Type: | 1 | 0 | 1 | 518 |
 |  doDOC Write better, faster, together | Part of Envision Pharma Group With doDOC, teams have the power to write and review scientific documents 70% faster, collaborating in real-time with full control, traceability, and automation of actions. doDOC is the only real-time collaborative editor for writing and reviewing scientific documents, allowing teams to control permissions on a granular level, have full traceability on actions, automate tasks, and benefit from flexible integrations that build on top of existing systems. As an iEnvision product, doDOC is part of the Envision Pharma Group and serves enterprise clients in diverse industries, but its main focus is … Type: | 4 | 1 | 3 | 20 |
 | Medable, Inc The leading global platform for decentralized clinical trials. Medable's mission is to get effective therapies to patients faster. We provide an end-to-end, global cloud platform with a flexible suite of tools that allows sponsors, patients, providers & CRO's to work together as a team in clinical trials. Our solutions enable more efficient clinical research, more effective healthcare delivery, and more accurate precision and predictive medicine. Our vision is to accelerate the path to human discovery and medical cures. We are passionate about driving innovation and empowering consumers. We are proactive, collaborative, self-motivated learners, committed, bold and tenacious. We are dedicated … Type: | 18 | 1 | 15 | 407 |
 | Evoke Canale Evoke Canale is now Inizio Evoke Comms, an award-winning global comms agency that harnesses insights, experience, and creativity to address today's greatest healthcare challenges. Proudly part of Inizio Evoke, a global health marketing, communications, and transformation platform unlocking growth through data-driven insights and human centricity. We are purpose-built to make Health more humanTM. Follow Inizio Evoke to stay up-to-date with news, insights, and career opportunities from Inizio Evoke Comms. corporate communications, public relations, investor relations, product marketing, website development, thought leadership strategy, scientific illustrations, brand and logo development, social media strategy, conference communications, healthcare, pharmaceuticals, and biotechnology Type: | 19 | 0 | 20 | 23 |
 | AXON Igniting change in healthcare through the power of communication. AXON is a global healthcare communications agency that ignites change in healthcare. Through the power of life-changing communications, we contribute to medical advances that improve lives. At the core of every scientific innovation and advancement, there is a simple and compelling story to be told. We know how to tell that story, how to use the right tools to reach the right audiences at the right time, to provoke meaningful change. We specialize in advising clients on medical affairs, clinical studies, real-world evidence, marketing, advocacy, and communications, all underpinned by insights … Type: | 3 | 0 | 2 | 155 |
NGO, Think-tanks, Ed, & Culture